Insider Transactions in Q2 2022 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.01%
|
$11,000
$11.75 P/Share
|
|
Jun 30
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
965
+1.5%
|
$10,615
$11.75 P/Share
|
|
Jun 30
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.13%
|
$11,000
$11.75 P/Share
|
|
May 04
2022
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+31.56%
|
-
|
|
May 04
2022
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+15.52%
|
-
|
|
May 04
2022
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+19.46%
|
-
|
|
May 04
2022
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+18.57%
|
-
|
|
May 04
2022
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+31.75%
|
-
|
|
May 04
2022
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+19.46%
|
-
|
|
May 04
2022
|
Philip J. Vickers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+16.93%
|
-
|